Skip to main content
Sign In

An official website of the United States government

U.S. Department of Health & Human Services

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Module 3: Oral Antiviral Administration

Patient Flow for Antiviral Oral Therapies

(When product not available onsite)

comments icon Assessment and Prescribing

Confirm diagnosis of COVID-19 infection

Discuss treatment with patient

  • Ensure patient meets treatment requirements and understands risks

Prescribe therapy for patient & provide the medication fact sheet (for product under EUA)

stethoscope icon Visit Discharge

Prescription provided to the patient

  • Ensure patient understands medication therapy being provided
  • Ensure medication therapy being dispensed complies with federal/state dispensing laws

Discuss treatment with patient

  • Ensure patient meets treatment requirements and understands risks

Prescribe therapy for patient & provide the medication fact sheet (for product under EUA)

  • Document required patient assessment in medical record
  • Provide patient education on medication therapy being prescribed

Determine locations medication is available in local area.

Return visit icon Post-visit

Pharmacist receives or prescribes patient prescription

  • Pharmacy should prioritize the prescription fill and ensure timely turnaround to support same day start for therapy
  • Pharmacist verifies prescription is appropriate for patient. Any concerns are clarified with prescribing provider

Pharmacy staff dispenses product to the patient

  • Patient is counseled on medication therapy and reminded to start immediately

Patient to begin prescribed therapy immediately and continue x 5 days

Patient to report any adverse effect to FDA MedWatch

  • Patients that present for hospital visit may continue their prescribed antiviral during hospitalization (at discretion of provider)

Test to Treat: About the Program

  • Overall goal of Test to Treat program is to increase access to COVID-19 oral therapeutics, particularly for individuals who don't have ready access to a health care provider.
  • Sites with Test to Treat services give patients the option to get tested, get assessed by a healthcare provider, and receive treatment – all in one visit.
  • COVID-19 treatments delivered as part of Test to Treat Program (Paxlovid and Lagevrio) must be taken within 5 days of initial COVID-19 symptoms.
  • Helps close gap between positive COVID-19 test and receiving treatment for those eligible.
  • An individual's healthcare providers remain the first option for care; Test to Treat sites are one additional access point.

Treatments Locator

treatment locator screenshot
  • The Treatments Locator displays pharmacies, clinics, and other locations with safe and effective COVID-19 medications.
  • Users can find locations offering Test to Treat, telehealth, home delivery, and testing services for eligible patients.
  • Locations participating in the U.S. Government Patient Assistance Program operated by Pfizer offering free Paxlovid for eligible patients are included on this website.
  • For questions regarding this site, contact 1-800-232-0233 (TTY 888-720-7489).

Find Test to Treat locations on the Treatments Locator

​